OrbiMed

4 stories about OrbiMed
בריאות דיגיטלית מדעי החיים רפואה טיפול 1

OrbiMed chooses against raising a third Israeli healthcare-dedicated fund

07.01.21|Meir Orbach
The investment firm raised a $307 million fund in 2016, but will not be founding another in a blow to the local ecosystem
default image

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
נאסדק נאסד"ק ניו יורק בורסה בועה

OrbiMed Invests $16 Million in Derma Company Foamix

17.04.18|Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
פיטר ת'יל יזם ו משקיע בתחום ה הייטק

Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb

04.12.17|Meir Orbach
ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases